Display options
Share it on

Int J Pediatr Endocrinol. 2015;2015(1):6. doi: 10.1186/s13633-015-0002-6. Epub 2015 Apr 15.

A novel homozygous SLC19A2 mutation in a Portuguese patient with diabetes mellitus and thiamine-responsive megaloblastic anaemia.

International journal of pediatric endocrinology

Sophia Tahir, Lieve Gj Leijssen, Maha Sherif, Carla Pereira, Anabela Morais, Khalid Hussain

Affiliations

  1. Developmental Endocrinology Research Group, Clinical and Molecular Genetics Unit, Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH UK.
  2. Endocrinology Unit, Department of Paediatrics, Hospital de Santa Maria - CHLN, Lisbon, Portugal.
  3. Hematology Unit, Department of Paediatrics, Hospital de Santa Maria - CHLN, Lisbon, Portugal.
  4. Department of Paediatric Endocrinology, Great Ormond Street Hospital for Children, NHS Foundation Trust, WC1N 3JH London, United Kingdom.

PMID: 25878670 PMCID: PMC4397709 DOI: 10.1186/s13633-015-0002-6

Abstract

Thiamine-responsive megaloblastic anaemia (TRMA) is a rare syndrome where patients present with early onset diabetes mellitus, megaloblastic anaemia and sensorineural deafness. This report describes a new case of TRMA syndrome in a female patient of Portuguese descent, born to unrelated parents. The patient was found to have a novel homozygous change R397X in exon 4 of the SLC19A2 gene, leading to a premature stop codon. The patient's diabetes and anaemia showed a good response to daily thiamine doses, reducing the daily insulin dose requirement. The report further indicates that TRMA is not only limited to consanguineous or ethnically isolated families, and should be considered as a differential diagnosis for patients presenting with suggestive clinical symptoms.

Keywords: Diabetes mellitus; Megaloblastic anaemia; SLC19A2 mutation; Sensorineural deafness; TRMA

References

  1. Diabetes Care. 1998 Jan;21(1):38-41 - PubMed
  2. Am J Hum Genet. 1997 Dec;61(6):1335-41 - PubMed
  3. Pediatr Diabetes. 2002 Dec;3(4):205-9 - PubMed
  4. Eur J Endocrinol. 2006 Dec;155(6):787-92 - PubMed
  5. Gene. 2013 May 1;519(2):295-7 - PubMed
  6. J Assoc Res Otolaryngol. 2006 Sep;7(3):211-7 - PubMed
  7. Acta Paediatr. 2006 Jan;95(1):99-104 - PubMed
  8. Nat Genet. 1999 Jul;22(3):300-4 - PubMed
  9. Pediatr Blood Cancer. 2014 Mar;61(3):528-31 - PubMed
  10. Turk J Pediatr. 2009 May-Jun;51(3):301-4 - PubMed
  11. J Pediatr. 1969 Apr;74(4):494-504 - PubMed
  12. Pediatr Diabetes. 2013 Aug;14(5):384-7 - PubMed
  13. Eur J Pediatr. 2014 Dec;173(12):1663-5 - PubMed
  14. Eur J Pediatr. 2012 Nov;171(11):1711-5 - PubMed
  15. PLoS One. 2012;7(10):e46688 - PubMed
  16. Hum Mol Genet. 2002 Nov 1;11(23):2951-60 - PubMed
  17. J Clin Invest. 1999 Mar;103(5):723-9 - PubMed
  18. Audiol Neurootol. 2012;17(5):309-20 - PubMed
  19. J Biol Chem. 1999 Nov 5;274(45):31925-9 - PubMed
  20. J Pediatr. 2009 Dec;155(6):888-892.e1 - PubMed
  21. Experientia. 1977 Feb 15;33(2):169-70 - PubMed
  22. Nat Genet. 1999 Jul;22(3):305-8 - PubMed
  23. Mol Genet Metab. 2001 Sep-Oct;74(1-2):273-80 - PubMed
  24. J Lab Clin Med. 1982 May;99(5):701-8 - PubMed
  25. Biochem Int. 1991 Oct;25(3):577-83 - PubMed
  26. Experientia. 1977 Feb 15;33(2):211-3 - PubMed
  27. Hum Mutat. 2003 Jun;21(6):577-81 - PubMed
  28. Gastroenterology. 2010 May;138(5):1802-9 - PubMed
  29. Am J Clin Nutr. 1997 Aug;66(2):320-6 - PubMed
  30. J Clin Res Pediatr Endocrinol. 2013 Sep 10;5(3):199-201 - PubMed

Publication Types